Real-World Outcomes of Abemaciclib Dose-Escalation Strategy in High-Risk Early Breast Cancer.
Saved in:
| Title: | Real-World Outcomes of Abemaciclib Dose-Escalation Strategy in High-Risk Early Breast Cancer. |
|---|---|
| Authors: | Lad N; Department of Clinical Pharmacy, The University of Kansas Cancer Center, Westwood, KS. Electronic address: noor15@kumc.edu., Blocker S; Department of Clinical Pharmacy, The University of Kansas Cancer Center, Westwood, KS., Monson T; Department of Clinical Pharmacy, The University of Kansas Cancer Center, Westwood, KS., Grauer D; Department of Pharmacy Practice, The University of Kansas School of Pharmacy, Kansas City, KS., O'Dea A; Department of Breast Oncology, The University of Kansas Cancer Center, Westwood, KS. |
| Source: | Clinical breast cancer [Clin Breast Cancer] 2026 May; Vol. 26 (5), pp. 57-62. Date of Electronic Publication: 2026 Apr 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1938-0666 |
|---|---|
| DOI: | 10.1016/j.clbc.2026.03.008 |
